Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors.
Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors.
复制标题
烷基取代的聚氨基异羟肟酸:一类新型的靶向组蛋白脱乙酰酶抑制剂。
DOI:
10.1021/jm0505009
复制
发表时间:
2005
影响因子:
7.3
通讯作者:
Woster,PatrickM
中科院分区:
文献类型:
--
作者:
Varghese,Sheeba;Gupta,Deepak;Baran,Tiffany;Jiemjit,Anchalee;Gore,StevenD;CaseroJr,RobertA;Woster,PatrickM
The reversible acetylation of histones is critical for regulation of eukaryotic gene expression. The histone deacetylase inhibitors trichostatin (TSA,1), MS-275 (2) and suberoylanilide hydroxamic acid (SAHA,3) arrest growth in transformed cells and in human tumor xenografts. However,1−3suffer from lack of specificity among the various HDAC isoforms, prompting us to design and synthesize polyaminohydroxamic acid (PAHA) derivatives6−21. We felt that PAHAs would be selectively directed to chromatin and associated histones by the positively charged polyamine side chain. At 1 μM, compounds12,15and20inhibited HDAC by 74.86, 59.99 and 73.85%, respectively. Although20was a less potent HDAC inhibitor than1, it was more potent than2, more effective as an initiator of histone hyperacetylation, and significantly more effective than2at re-expressing p21Waf1in ML-1 leukemia cells. On the basis of these results, PAHAs6−21represent an important new chemical class of HDAC inhibitors.